Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HI FPV Study: Using Observational Cohorts to Monitor Safety of Fosamprenavir in Patients With Mild/Moderate Hepatic Impairment

NCT01054586 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01054586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01054586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HI FPV Study: Using Observational Cohorts to Monitor Safety of Fosamprenavir in Patients With Mild/Moderate Hepatic Impairment
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
March 31, 2012
Enrollment
167 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infection, human immunodeficiency virus